neuroClues
PrivateLast Round
Series A
Apr 7, 2026
Total Funding Raised
$19.24M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
neuroClues is a MedTech company that provides an AI-driven eye-tracking device for clinicians to aid in the early diagnosis of neurological disorders such as Parkinson's Disease, Alzheimer's Disease, and Multiple Sclerosis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
neuroClues Comparables
Compare neuroClues with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuroSync | 81% | |
| ViewMind Inc. | 81% | |
| RightEye | 81% |
neuroClues Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 7, 2026 | ||||
| VC Round | Apr 30, 2024 | ||||
| Grant | Dec 19, 2022 | ||||
| Seed | Nov 8, 2021 |
Key People
Founding team and executive leadership
neuroClues Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series A |
| Wallonie Entreprendre | Series A, VC Round, Seed |
| White Fund | Series A, VC Round |
| Nivelinvest | Series A, VC Round, Seed |
| EIC Accelerator | Grant, VC Round |
| Teampact Ventures | Series A |
| LeanSquare | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 19, 54% of headcount.
- Jul 20, 2026
Open roles increased to 19, 54% of headcount.
neuroClues Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about neuroClues's valuation, stock price, and market status.
Is neuroClues a public or private company?
neuroClues is a private company.
What is the current stock price of neuroClues?
neuroClues is a private company, so its shares have no public market price. Caplight tracks neuroClues's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is neuroClues worth (valuation)?
Valuation information for neuroClues is not publicly available.
Can I buy neuroClues stock?
neuroClues shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was neuroClues's last funding round?
neuroClues's most recent funding round was Series A on April 7, 2026.
Who are the main investors in neuroClues?
Key investors in neuroClues include European Innovation Council Fund, White Fund, EIC Accelerator, Teampact Ventures, EIC Fund.
Will neuroClues IPO soon?
No public IPO plans have been announced for neuroClues.
How can I track neuroClues secondary market activity?
Caplight tracks bids, offers, and trades in neuroClues's shares on secondary markets.